SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001587221-21-000033
Filing Date
2021-11-10
Accepted
2021-11-10 16:31:43
Documents
65
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q zsan-20210930.htm   iXBRL 10-Q 1642521
2 EX-31.1 exhibit311q3-202110q.htm EX-31.1 9711
3 EX-31.2 exhibit312q3-202110q.htm EX-31.2 9629
4 EX-32.1 exhibit321q3-202110q.htm EX-32.1 8901
  Complete submission text file 0001587221-21-000033.txt   6664099

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zsan-20210930.xsd EX-101.SCH 53069
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT zsan-20210930_cal.xml EX-101.CAL 75900
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zsan-20210930_def.xml EX-101.DEF 214506
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zsan-20210930_lab.xml EX-101.LAB 559891
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zsan-20210930_pre.xml EX-101.PRE 348073
10 EXTRACTED XBRL INSTANCE DOCUMENT zsan-20210930_htm.xml XML 1033028
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36570 | Film No.: 211397179
SIC: 2834 Pharmaceutical Preparations